Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Effects of GvHD Prophylaxis with Post-Transplant Cyclophosphamide on Immune Reconstitution and TCR Repertoire after Haploidentical and HLA-Matched Transplantation Compared to Prophylaxis with Calcineurin Inhibitor Plus Methotrexate in HLA-Matched Transplantation

Michela Ansuinelli, Haesook T. Kim, Carol G. Reynolds, Francesco Malfona, Shuntaro Ikegawa, Rakuyo Tamada, Roman M. Shapiro, Mahasweta Gooptu, Rizwan Romee, Sarah Nikiforow, John Koreth, Vincent T. Ho, Corey S. Cutler, Joseph H. Antin, Leslie Kean, Robert J. Soiffer, Jerome Ritz

Blood (2024) 144 (Supplement 1): 1041.

https://doi.org/10.1182/blood-2024-201835

Published: 2024

Journal Articles

Prolonged Persistence and Functional Activity of Anti-BCMA CAR-T Durcabtagene Autoleucel (PHE885) Manufactured Using the T-Charge™ Platform

Blood (2024) 144 (Supplement 1): 149.

https://doi.org/10.1182/blood-2024-199890

Published: 2024

Journal Articles

Heterogeneity of PD-1 + regulatory T Cells after Low-Dose IL-2 Therapy for Patients with Chronic Graft-Versus-Host Disease

Blood (2024) 144 (Supplement 1): 379.

https://doi.org/10.1182/blood-2024-200128

Published: 2024

Journal Articles

T-Charge™ Manufacturing of the Anti-BCMA CAR-T, Durcabtagene Autoleucel (PHE885), Promotes Expansion and Persistence of CAR-T Cells with High TCR Repertoire Diversity

Shuntaro Ikegawa, Adam S. Sperling, Michela Ansuinelli, Sarah Nikiforow, David Quinn, Dexiu Bu, Jennifer Mataraza, David Pearson, Lawrence Rispoli, Marc A Credi, Nina Orwitz, Yohei Arihara, Rao Prabhala, Lakshmi Bhavani Potluri, Carol Reynolds, Serena De Vita, Nikhil C Munshi, Jerome Ritz

Blood (2023) 142 (Supplement 1): 3469.

https://doi.org/10.1182/blood-2023-177721

Published: 2023

Journal Articles

Phase I Study of PHE885, a Fully Human BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <2 Days Using the T-Charge TM Platform

Blood (2021) 138 (Supplement 1): 3864.

https://doi.org/10.1182/blood-2021-146646

Published: 2021

Journal Articles

Posttransplant Cyclophosphamide Promote Naïve-Subset Dominant B Cell Recovery Coordinated with Early Treg Expansion; Implication of Reduced Risk of Pathogenesis into Chronic Gvhd

Miki Iwamoto, Yusuke Meguri, MD, Takumi Kondo, MD, Hiroyuki Sugiura, MD, Shuntaro Ikegawa, MD, Yasuhisa Sando, MD, Makoto Nakamura, MD, Yoshinobu Maeda, MD PhD, Ken-Ichi Matsuoka, MD PhD

Blood (2018) 132 (Supplement 1): 4566.

https://doi.org/10.1182/blood-2018-99-120081

Published: 2018

Journal Articles

Mechanistic Analysis of Prolonged Negative Impacts of Anti-CCR4 Antibody Mogamulizumab on Regulatory T Cell Homeostasis after Allogeneic Hematopoietic Stem Cell Transplantation

Yasuhisa Sando, MD, Ken-Ichi Matsuoka, MD PhD, Yusuke Meguri, MD, Takumi Kondo, MD, Shuntaro Ikegawa, MD, Hiroyuki Sugiura, MD, Makoto Nakamura, MD, Miki Iwamoto, Takeru Asano, Takanori Yoshioka, MD, Yoshinobu Maeda, MD PhD

Blood (2018) 132 (Supplement 1): 3400.

https://doi.org/10.1182/blood-2018-99-117548

Published: 2018

Journal Articles

Post-Transplant Cyclophosphamide Ameliorates Lethal Thymic GVHD By Restoring Regulatory and Effector T Cell Homeostasis in Recipients with Prior PD-1 Blockade Therapy

Shuntaro Ikegawa, MD, Yusuke Meguri, MD, Takumi Kondo, MD, Hiroyuki Sugiura, MD, Yasuhisa Sando, MD, Makoto Nakamura, MD, Miki Iwamoto, Yoshinobu Maeda, MD PhD, Ken-Ichi Matsuoka, MD PhD

Blood (2018) 132 (Supplement 1): 479.

https://doi.org/10.1182/blood-2018-99-111142

Published: 2018

Journal Articles

Early Administration of Low-Dose IL-2 Intensify Graft-Versus-Leukemia Effect without Worsening GVHD through Sequential Enhancement of Effector T Cell and CD62L+ Regulatory T Cell Subset

Yusuke Meguri, MD, Ken-ichi Matsuoka, MDPhD, Shuntaro Ikegawa, MD, Hiroyuki Sugiura, MD, Makoto Nakamura, MD, Yasuhisa Sando, MD, Iwamoto Miki, Takanori Yoshioka, MD, Takeru Asano, MD, Yoshinobu Maeda, MDPhD

Blood (2017) 130 (Supplement 1): 3192.

https://doi.org/10.1182/blood.V130.Suppl_1.3192.3192

Published: 2017

Journal Articles

Liposomal Alpha-Galactosylceramide Ameliorates Graft-Versus-Host Disease with Remaining Intensified GVL Gained By Dose-Reduction of Posttransplant Cyclophosphamaide after Haploidentical HSCT

Makoto Nakamura, MD, Ken-ichi Matsuoka, MDPhD, Yusuke Meguri, MD, Shuntaro Ikegawa, MD, Hiroyuki Sugiura, MD, Yasuhisa Sando, MD, Miki Iwamoto, Takeru Asano, MD, Yasuyuki Ishii, PhD, Yoshinobu Maeda, MDPhD

Blood (2017) 130 (Supplement 1): 1897.

https://doi.org/10.1182/blood.V130.Suppl_1.1897.1897

Published: 2017

Journal Articles

Essential Role of Regulatory T Cells on Early B Cell Reconstitution after Haploidentical BMT with Posttransplant Cyclophosphamide

Miki Iwamoto, Ken-ichi Matsuoka, MDPhD, Yusuke Meguri, MD, Shuntaro Ikegawa, MD, Hiroyuki Sugiura, MD, Yasuhisa Sando, MD, Makoto Nakamura, MD, Takeru Asano, MD, Yoshinobu Maeda, MDPhD

Blood (2017) 130 (Supplement 1): 4447.

https://doi.org/10.1182/blood.V130.Suppl_1.4447.4447

Published: 2017

Journal Articles

Granulocyte Transfusions for Neutropenic Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Shuntaro Ikegawa, MD, Nobuharu Fujii, MD PhD, Keiko Fujii, MD PhD, Yusuke Meguri, MD, Kyosuke Saeki, MD, Noboru Asada, MD PhD, Hisakazu Nishimori, MD PhD, Ken-ichi Matsuoka, MDPhD, Yoshinobu Maeda, MDPhD

Blood (2017) 130 (Supplement 1): 2410.

https://doi.org/10.1182/blood.V130.Suppl_1.2410.2410

Published: 2017

Journal Articles

Loss of the GVL Effect By Distinct Expression of Migration Markers As a Mechanism of Immune Escape in Adult T Cell Leukemia/Lymphoma (ATLL), a Malignant Counterpart of Regulatory T Cells

Yasuhisa Sando, MD, Ken-ichi Matsuoka, MDPhD, Yusuke Meguri, MD, Shuntaro Ikegawa, MD, Hiroyuki Sugiura, MD, Makoto Nakamura, MD, Iwamoto Miki, Takeru Asano, MD, Takanori Yoshioka, MD, Yoshinobu Maeda, MDPhD

Blood (2017) 130 (Supplement 1): 2760.

https://doi.org/10.1182/blood.V130.Suppl_1.2760.2760

Published: 2017

Journal Articles

Impact of Incomplete Blood Count Recovery Prior to Allogeneic Hematopoietic Stem Cell Transplantation on Engraftment and Early Infection in Patients with Acute Myeloid Leukemia

Takeru Asano, MD, Shuntaro Ikegawa, MD, Tomoko Inomata, MD, Naoto Ikeda, MD, Hiroyuki Sugiura, MD, Taiga Kuroi, MD, Shohei Yoshida, MD, Hisakazu Nishimori, MD PhD, Ken-ichi Matsuoka, MD PhD, Nobuharu Fujii, MD PhD, Eisei Kondo, MD PhD, Yoshinobu Maeda, MD PhD, Mitsune Tanimoto, MD PhD

Blood (2016) 128 (22): 3408.

https://doi.org/10.1182/blood.V128.22.3408.3408

Published: 2016

Journal Articles

Successful Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mild Renal Dysfunction Calculated By Creatinin Clearance

Shuntaro Ikegawa, MD, Tomoko Inomata, MD, Naoto Ikeda, MD, Hiroyuki Sugiura, MD, Taiga Kuroi, MD, Takeru Asano, MD, Shohei Yoshida, MD, Hisakazu Nishimori, MD PhD, Ken-ichi Matsuoka, MD PhD, Nobuharu Fujii, MD PhD, Eisei Kondo, MD PhD, Yoshinobu Maeda, MD PhD, Mitsune Tanimoto, MD PhD

Blood (2016) 128 (22): 4656.

https://doi.org/10.1182/blood.V128.22.4656.4656

Published: 2016

Journal Articles

Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut

Kazuhiko Kakihana, Yuki Fujioka, Wataru Suda, Yuho Najima, Go Kuwata, Satoshi Sasajima, Iyo Mimura, Hidetoshi Morita, Daisuke Sugiyama, Hiroyoshi Nishikawa, Masahira Hattori, Yutaro Hino, Shuntaro Ikegawa, Keita Yamamoto, Takashi Toya, Noriko Doki, Koichi Koizumi, Kenya Honda, Kazuteru Ohashi

Blood (2016) 128 (16): 2083–2088.

https://doi.org/10.1182/blood-2016-05-717652

Published: 2016

Includes: Supplemental data

Journal Articles

Retrospective Evaluation of Incidence and Prognostic Factors for Stenotrophomonas Maltophilia Bacteremia Following Allogeneic Hematopoietic Stem Cell Transplantation

Blood (2015) 126 (23): 4626.

https://doi.org/10.1182/blood.V126.23.4626.4626

Published: 2015

Journal Articles

Clinical Impact of CD25 Expression of Leukemic Blasts on Subsequent Transplant Outcomes in Patients with Refractory or Relapsed Acute Myeloid Leukemia

Shuntaro Ikegawa, MD, Noriko Doki, MD PhD, Keita Yamamoto, MD, Yutaro Hino, MD, Kaito Harada, MD, Naoki Shingai, MD, Ken Watanabe, MD PhD, Yasushi Senoo, MD, Aiko Igarashi, MD, Yuho Najima, MDPhD, Takeshi Kobayashi, MD, Kazuhiko Kakihana, MD PhD, Hisashi Sakamaki, MDPhD, Kazuteru Ohashi, MD PhD

Blood (2014) 124 (21): 2589.

https://doi.org/10.1182/blood.V124.21.2589.2589

Published: 2014

Journal Articles

An Increase in Baseline Level of Urinary Liver-Type Fatty Acid-Binding Protein Linked with Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation

Naoki Shingai, MD, Taku Morito, MD PhD, Shuntaro Ikegawa, MD, Keita Yamamoto, MD, Yutaro Hino, MD, Kaito Harada, MD, Aiko Igarashi, MD, Ken Watanabe, MD PhD, Yasushi Senoo, MD, Yuho Najima, MDPhD, Noriko Doki, MD PhD, Takeshi Kobayashi, MD, Kazuhiko Kakihana, MD PhD, Kazuteru Ohashi, MD PhD, Hisashi Sakamaki, MDPhD, Minoru Ando, MD PhD

Blood (2014) 124 (21): 3861.

https://doi.org/10.1182/blood.V124.21.3861.3861

Published: 2014

Journal Articles

The Clinical Significance Of Diastolic Dysfunction On The Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Naoki Shingai, MD, Kazuhiko Kakihana, MD, PhD, Shuntaro Ikegawa, MD, Yukie Takahashi, MD, Jun Aoki, MD, Kosuke Yoshioka, MD, Kensuke Narukawa, M.D., Ph.D., Shinya Ishida, MD, Aiko Igarashi, MD, Takeshi Kobayashi, MD, Noriko Doki, MD, PhD, Ohashi Kazuteru, MD, PhD, Hisashi Sakamaki, MD, PhD

Blood (2013) 122 (21): 4550.

https://doi.org/10.1182/blood.V122.21.4550.4550

Published: 2013

NARROW

Effects of GvHD Prophylaxis with Post-Transplant Cyclophosphamide on Immune Reconstitution and TCR Repertoire after Haploidentical and HLA-Matched Transplantation Compared to Prophylaxis with Calcineurin Inhibitor Plus Methotrexate in HLA-Matched Transplantation

Prolonged Persistence and Functional Activity of Anti-BCMA CAR-T Durcabtagene Autoleucel (PHE885) Manufactured Using the T-Charge™ Platform

Heterogeneity of PD-1 + regulatory T Cells after Low-Dose IL-2 Therapy for Patients with Chronic Graft-Versus-Host Disease

T-Charge™ Manufacturing of the Anti-BCMA CAR-T, Durcabtagene Autoleucel (PHE885), Promotes Expansion and Persistence of CAR-T Cells with High TCR Repertoire Diversity

Phase I Study of PHE885, a Fully Human BCMA-Directed CAR-T Cell Therapy for Relapsed/Refractory Multiple Myeloma Manufactured in <2 Days Using the T-Charge TM Platform

Posttransplant Cyclophosphamide Promote Naïve-Subset Dominant B Cell Recovery Coordinated with Early Treg Expansion; Implication of Reduced Risk of Pathogenesis into Chronic Gvhd

Mechanistic Analysis of Prolonged Negative Impacts of Anti-CCR4 Antibody Mogamulizumab on Regulatory T Cell Homeostasis after Allogeneic Hematopoietic Stem Cell Transplantation

Post-Transplant Cyclophosphamide Ameliorates Lethal Thymic GVHD By Restoring Regulatory and Effector T Cell Homeostasis in Recipients with Prior PD-1 Blockade Therapy

Early Administration of Low-Dose IL-2 Intensify Graft-Versus-Leukemia Effect without Worsening GVHD through Sequential Enhancement of Effector T Cell and CD62L+ Regulatory T Cell Subset

Liposomal Alpha-Galactosylceramide Ameliorates Graft-Versus-Host Disease with Remaining Intensified GVL Gained By Dose-Reduction of Posttransplant Cyclophosphamaide after Haploidentical HSCT

Essential Role of Regulatory T Cells on Early B Cell Reconstitution after Haploidentical BMT with Posttransplant Cyclophosphamide

Granulocyte Transfusions for Neutropenic Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Loss of the GVL Effect By Distinct Expression of Migration Markers As a Mechanism of Immune Escape in Adult T Cell Leukemia/Lymphoma (ATLL), a Malignant Counterpart of Regulatory T Cells

Impact of Incomplete Blood Count Recovery Prior to Allogeneic Hematopoietic Stem Cell Transplantation on Engraftment and Early Infection in Patients with Acute Myeloid Leukemia

Successful Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Mild Renal Dysfunction Calculated By Creatinin Clearance

Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut

Retrospective Evaluation of Incidence and Prognostic Factors for Stenotrophomonas Maltophilia Bacteremia Following Allogeneic Hematopoietic Stem Cell Transplantation

Clinical Impact of CD25 Expression of Leukemic Blasts on Subsequent Transplant Outcomes in Patients with Refractory or Relapsed Acute Myeloid Leukemia

An Increase in Baseline Level of Urinary Liver-Type Fatty Acid-Binding Protein Linked with Poor Prognosis after Allogeneic Hematopoietic Stem Cell Transplantation

The Clinical Significance Of Diastolic Dysfunction On The Outcome After Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only